Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway. 2017

Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
Department of Infectious Disease,The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.

Andrographolide (ADH), a diterpenoid lactone extracted from Andrographis paniculata, has been found to have anti-inflammatory and anti-oxidative effects. However, its protective effects and mechanisms on liver injury have not been investigated clearly. This study takes an attempt to reveal the protective effects and mechanism of ADH on lipopolysaccharide (LPS) and D-galactosamine (D-GalN)-induced acute liver injury in mice. The mice liver injury model was induced by LPS (60 mg/kg) and D-GalN (800 mg/kg), and ADH was given 1 h after LPS and D-GalN treatment. Hepatic tissue histology was measured by H&E staining. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were detected by detection kits. The levels of TNF-α and IL-1β were detected by ELISA. Moreover, malondialdehyde (MDA) and reactive oxygen species (ROS) contents were also detected. Meanwhile, the expression of Nrf2, HO-1, and NF-κB were detected by western blot analysis. The results showed that ADH treatment improved liver histology and decreased the levels of ALT, AST, MPO, IL-1β, TNF-α, as well as MDA and ROS levels of hepatic tissues in a dose-dependent manner. ADH also inhibited LPS/D-GalN-induced NF-κB activation. The expression of Nrf2 and HO-1 were increased by treatment of ADH. In conclusion, ADH protected against LPS/D-GalN-induced liver injury by inhibiting NF-κB and activating Nrf2 signaling pathway.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D005688 Galactosamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
January 2016, European journal of pharmacology,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
July 2019, International immunopharmacology,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
September 2016, International immunopharmacology,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
June 2018, Microbial pathogenesis,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
July 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
April 2019, Cell death & disease,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
December 2017, The Journal of surgical research,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
April 2017, International immunopharmacology,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
February 2019, International immunopharmacology,
Chen-Wei Pan, and Shou-Xing Yang, and Zhen-Zhen Pan, and Bo Zheng, and Jian-Zhang Wang, and Guang-Rong Lu, and Zhan-Xiong Xue, and Chang-Long Xu
January 2023, Folia histochemica et cytobiologica,
Copied contents to your clipboard!